Aytu BioPharma Inc. (AYTU)
NASDAQ: AYTU
· Real-Time Price · USD
2.21
0.02 (0.91%)
At close: Aug 15, 2025, 3:59 PM
2.24
1.36%
After-hours: Aug 15, 2025, 05:41 PM EDT
Aytu BioPharma Balance Sheet Statement
Financials in USD. Fiscal
year is
July - June.
| Fiscal Year | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 |
Cash & Equivalents | 18.17M | 20.4M | 20.11M | 20.01M | 19.76M | 19.53M | 19.96M | 22.98M | 19.18M | 19.5M | 23.81M | 19.36M | 27.61M | 35.28M | 40.31M | 49.65M | 46.54M | 62.03M | 37.91M |
Short-Term Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Long-Term Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -1.38M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -10.91M | n/a | n/a | n/a |
Other Long-Term Assets | 1.32M | 1.52M | 1.97M | 2.23M | 889K | 907K | 772K | 792K | 892K | 821K | 829K | 766K | 774K | 457K | 465K | 465K | 164.48K | 14.74K | 10.36K |
Receivables | 35.83M | 25.4M | 23.16M | 23.62M | 29.93M | 29.4M | 29.88M | 28.94M | 34.04M | 25.55M | 27.92M | 21.71M | 27.61M | 22.99M | 21.63M | 28.18M | 28.27M | 7M | 6.11M |
Inventory | 11.06M | 11.09M | 11.74M | 12.63M | 13.19M | 13M | 12.97M | 11.99M | 13.64M | 12.95M | 12.87M | 10.85M | 13.89M | 16.56M | 16.31M | 16.34M | 16.58M | 6.57M | 11.48M |
Other Current Assets | 7.46M | 6.17M | 5.73M | n/a | 1M | 1.33M | 749K | 868K | 1.18M | 624K | 785K | 633K | 888K | 1.42M | 1.45M | 1.29M | 1.83M | 10.85M | 6.27M |
Total Current Assets | 72.51M | 63.05M | 60.74M | 61.89M | 71.13M | 71.37M | 70.6M | 72.83M | 78.47M | 70.61M | 74.42M | 59.93M | 77.95M | 87.54M | 89.04M | 105.23M | 100.01M | 92.54M | 65.45M |
Property-Plant & Equipment | 1.66M | 1.69M | 1.92M | 1.52M | 2.76M | 3.26M | 4.18M | 3.87M | 4.39M | 5.02M | 5.65M | 6.3M | 7.04M | 8.14M | 8.49M | 8.7M | 9.34M | 400.48K | 440.29K |
Goodwill & Intangibles | 48.71M | 49.96M | 51.2M | 52.45M | 54.08M | 55.71M | 57.34M | 58.97M | 63.46M | 64.98M | 69.11M | 70.63M | 83.06M | 127.69M | 129.73M | 151.27M | 162.04M | 73.79M | 75.37M |
Total Long-Term Assets | 51.69M | 53.17M | 55.09M | 56.2M | 57.73M | 59.88M | 62.29M | 63.63M | 68.75M | 70.83M | 75.58M | 77.69M | 90.88M | 136.28M | 138.69M | 160.43M | 171.54M | 74.2M | 75.82M |
Total Assets | 124.2M | 116.23M | 115.83M | 118.09M | 128.86M | 131.25M | 132.89M | 136.46M | 147.22M | 141.44M | 150M | 137.62M | 168.83M | 223.82M | 227.73M | 265.67M | 271.56M | 166.74M | 141.27M |
Account Payables | 12.04M | 11.7M | 13.51M | 10.44M | 10.47M | 10.47M | 14.47M | 13.48M | 14.67M | 10.58M | 14.67M | 10.99M | 11.13M | 15.6M | 9.38M | 19.25M | 16.53M | 7.16M | 5.77M |
Deferred Revenue | n/a | n/a | n/a | n/a | n/a | 43.41M | 40.73M | 46.8M | n/a | 100K | 100K | n/a | 100K | 55.73M | 59.14M | 57.23M | 53.04M | 475.68K | 232.58K |
Short-Term Debt | 11.88M | 5.87M | 6.13M | 4.25M | 25.86M | 39K | 1.28M | 85K | 22.41M | 7.43M | 9.01M | 3.91M | 3.48M | 23.55M | 21.03M | 24.6M | 6.12M | 753.32K | 1.58M |
Other Current Liabilities | 15.59M | 16.19M | 17.32M | 42.6M | 24.52M | 50.31M | 19.44M | 49.78M | 41.47M | 24.32M | 25.72M | 15.89M | 29.64M | 28.29M | 36.42M | 34.76M | 32.05M | 10.82M | 7.32M |
Total Current Liabilities | 70.71M | 64.05M | 61.25M | 62.23M | 83.69M | 64.19M | 65.46M | 69.02M | 85.42M | 67.15M | 73.2M | 64.44M | 80.36M | 100.57M | 98M | 109.44M | 83.68M | 25.81M | 21.51M |
Long-Term Debt | 9.54M | 9.98M | 10.43M | 10.88M | n/a | 14.98M | 14.84M | 14.71M | n/a | 14.49M | 13.56M | 14.2M | 14.06M | n/a | 154K | 2.8M | 16.93M | n/a | n/a |
Other Long-Term Liabilities | 9.06M | 11.43M | 14.32M | 17.27M | 14.4M | 19.23M | 20.35M | 13.38M | 19.72M | 12.46M | 9.33M | 12.89M | 6.51M | 14.87M | 15.17M | 13.23M | 24.92M | 28.02M | 28.46M |
Total Long-Term Liabilities | 18.6M | 21.41M | 24.75M | 28.15M | 14.4M | 34.21M | 35.26M | 28.09M | 20.89M | 28.47M | 22.89M | 27.09M | 27.32M | 17.72M | 18.23M | 18.66M | 44.72M | 28.24M | 28.7M |
Total Liabilities | 89.3M | 85.46M | 86M | 90.38M | 98.09M | 98.4M | 100.72M | 97.11M | 106.3M | 95.62M | 96.09M | 91.53M | 107.68M | 118.29M | 116.23M | 128.1M | 128.41M | 54.05M | 50.21M |
Total Debt | 21.42M | 15.85M | 16.56M | 15.13M | 31.65M | 16.04M | 16.12M | 16.36M | 25.09M | 22.05M | 22.57M | 18.19M | 21.26M | 27.57M | 25.02M | 28.35M | 26.83M | 1.06M | 1.92M |
Common Stock | 1K | 1K | 1K | 1K | 1K | 1K | 1K | 1K | n/a | n/a | 6K | 4K | 3K | 3K | 3K | 3K | 2.35K | 1.79K | 12.58K |
Retained Earnings | -313.72M | -317.71M | -318.5M | -319.97M | -315.36M | -312.47M | -312.25M | -304.13M | -301.67M | -294.47M | -291.35M | -288.47M | -270.77M | -217.7M | -206.15M | -178.3M | -159.3M | -133.84M | -124.32M |
Comprehensive Income | n/a | n/a | n/a | n/a | n/a | -0.00 | n/a | n/a | n/a | n/a | n/a | -0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 302.45M | n/a | -0.00 |
Shareholders Equity | 34.9M | 30.77M | 29.83M | 27.72M | 30.78M | 32.85M | 32.17M | 39.36M | 40.91M | 45.82M | 53.91M | 46.09M | 61.14M | 105.54M | 111.5M | 137.57M | 143.15M | 112.69M | 91.06M |
Total Investments | n/a | n/a | n/a | -762K | n/a | n/a | n/a | -1.38M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -10.91M | n/a | n/a | n/a |